Therapeutic effect of human clonal bone marrow-derived mesenchymal stem cells in severe acute pancreatitis

  title={Therapeutic effect of human clonal bone marrow-derived mesenchymal stem cells in severe acute pancreatitis},
  author={Kyung Hee Jung and Tacghee Yi and Mi kwon Son and Sun U. Song and Soon-Sun Hong},
  journal={Archives of Pharmacal Research},
Severe acute pancreatitis (SAP), a common necroinflammatory disease initiated by the premature activation of digestive enzymes within the pancreatic acinar cells, is associated with significant morbidity and mortality. In this study, we investigated whether human bone marrow-derived clonal mesenchymal stem cells (hcMSCs), isolated from human bone marrow aspirate according to our newly established isolation protocol, have potential therapeutic effects in SAP. SAP was induced by three… 

Human Bone Marrow Mesenchymal Stromal Cells Attenuate Tissue Injury and Reduce Inflammation in Experimental Acute Pancreatitis

It is demonstrated that hBM- MSC attenuates AP signs and indicating that hMB-MSCtherapy could be a suitable approach for the treatment of inflammatory disease such as AP.

Canine adipose tissue-derived mesenchymal stem cells ameliorate severe acute pancreatitis by regulating T cells in rats

Results indicate that cAT-MSCs can be effective as a cell-based therapeutic strategy for treatment of SAP in dogs.

Therapeutic Use of Adipose-Derived Stromal Cells in a Murine Model of Acute Pancreatitis

Intravenous delivery of human ASCs markedly reduces pancreatic inflammation in a murine model of AP ASCs which represent an effective therapy for AP.

Granulocyte colony-stimulating factor enhances the therapeutic efficacy of bone marrow mesenchymal stem cell transplantation in rats with experimental acute pancreatitis

G-CSF therapy with BMMSC transplantation improves histological and functional outcomes in rats with experimental AP and shows better recovery in terms of tissue regeneration and blood biochemical levels than other groups.

N-Acetylcysteine enhances the therapeutic efficacy of bone marrow-derived mesenchymal stem cell transplantation in rats with severe acute pancreatitis.

Placental chorionic plate-derived mesenchymal stem cells ameliorate severe acute pancreatitis by regulating macrophage polarization via secreting TSG-6

Exogenous CP-MSCs tended to colonize in the injured tissue and reduced pancreatic injury and systemic inflammation in SAP rats through inducing M2 polarization of macrophages by secreting TSG-6.

Bone marrow-derived mesenchymal stem cells alleviates renal injury in severe acute pancreatitis via RhoA/Rho kinase.

Results indicated that BMSCs can alleviate SAP rat kidney injury by inhibiting the RhoA/Rho kinase signaling pathways, increase the ZO-1 expression, reduce capillary permeability, blood capillary leakage and improve renal function.

Effect of bone marrow mesenchymal stem cells on RhoA/ROCK signal pathway in severe acute pancreatitis.

Pancreatic expression of RhoA and ROCK I is up-regulated in SAP, with severe pancreatic tissue damage, and BMSCs can alleviate pancreatic injury possibly through decreasing serum inflammatory factor level and inhibiting RHoA/ROCK signal pathway.

Comparative Histological Study on The Effect of Bone Marrow-Derived Mesenchymal Stem Cells Versus Wheat Germ Oil on Acute Pancreatitis in A Rat Model

BMSCs possess better therapeutic efficacy in treating AP compared with WGO, and showed improvement in the biochemical, histological and immunohistochemical results with better results in BMSCs group.



Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats.

Human bone marrow-derived clonal MSCs underwent self-renewal and had multipotent differentiation capacities and immunoregulatory functions and might be developed as a cell therapy for pancreatitis.

Therapeutic effect of human umbilical cord-derived mesenchymal stem cells in rat severe acute pancreatitis.

Transplantation of UC-MSCs significantly inhibits inflammation and decreases pancreatic injury secondary to SAP and significantly attenuated in SAP+MSCs group.

Role of bone marrow-derived mesenchymal stem cells in a rat model of severe acute pancreatitis.

MSCs can effectively relieve injury to pancreatic acinar cells and small intestinal epithelium, promote the proliferation of enteric epithelia and repair of the mucosa, attenuate systemic inflammation in rats with SAP.

Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury.

The results of this study suggest that uMSCs have antifibrotic properties and may augment lung repair if used to treat acute respiratory distress syndrome.

Mesenchymal stem cells in acute kidney injury.

Current knowledge is summarized and gaps in understanding of MSC biology that will need to be filled in order to translate recent discoveries into therapies for AKI in humans are identified.

The SDF-1/CXCR4 axis regulates migration of transplanted bone marrow mesenchymal stem cells towards the pancreas in rats with acute pancreatitis

The results demonstrated that the expression of SDF-1 was significantly increased in the injured pancreas, and that these levels peaked on days 5–7 and began to decrease on day 10, which indicates that the interaction of locally produced S DF-1 with CXCR4 on B MSCs, has an important regulatory role in the migration of BMSCs towards the injured pancreatitis in AP.

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease.

The current understanding of MSC biology, mechanism of action in cardiac repair, translational findings, and early clinical trial data of M SC therapy for cardiac disease are reviewed.

Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model.

An immediate temporal tissue effect in response to MSC transplantation is shown that may represent a novel indirect paracrine mechanism for the beneficial effects of cell transplantation observed in injured tissues.

Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo

An antioxidant and neuroprotective activity for MSCs was confirmed in vitro on neuroblastoma cells exposed to an oxidative insult and administration of MSCS reduced the EAE‐induced increases in levels/activities of all these proteins.